Nisa Investment Advisors
CMPX icon

Nisa Investment Advisors’s Compass Therapeutics CMPX Stock Holding History

Nisa Investment Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
5,456
+208
+4% +$614 ﹤0.01% 2413
2026
Q1 		$27.8K Hold
5,248
– – ﹤0.01% 1894
2025
Q4 		$28.2K Hold
5,248
– – ﹤0.01% 1813
2025
Q3 		$18.4K Hold
5,248
– – ﹤0.01% 2043
2025
Q2 		$13.6K Buy
5,248
+4,400
+519% +$9.07K ﹤0.01% 2114
2025
Q1 		$1.61K Hold
848
– – ﹤0.01% 2525
2024
Q4 		$1.23K Buy
848
+419
+98% +$696 ﹤0.01% 2625
2024
Q3 		$789 Sell
429
-172
-29% -$214 ﹤0.01% 2628
2024
Q2 		$601 Buy
601
+581
+2,905% +$849 ﹤0.01% 2646
2024
Q1 		$40 Sell
20
-45
-69% -$78 ﹤0.01% 2756
2023
Q4 		$101 Buy
+65
New +$112 ﹤0.01% 2613

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nisa Investment Advisors's CMPX Position: Q2 2026 in Review

Nisa Investment Advisors increased its Compass Therapeutics (CMPX) stake by 4% in Q2 2026, buying an estimated $614 and bringing the position to 5,456 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Nisa Investment Advisors first reported a position in CMPX in Q4 2023 and has held it in 11 quarters since. The position peaked at $28.2K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Nisa Investment Advisors held 5,456 shares of Compass Therapeutics worth $11.9K as of Q2 2026.
  • Nisa Investment Advisors bought 208 Compass Therapeutics shares in Q2 2026, an estimated $614.
  • Compass Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2413 holding.
  • Nisa Investment Advisors first reported a position in Compass Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Compass Therapeutics position peaked at $28.2K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.